BA-1037

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBA-1037
Drug Alias NameBA-1037
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioaxone
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioaxone
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A